TABLE 3.
Patients with defective IFN-γ production upon PBMC stimulation
| Age (yr) | Sexa | Group | Clinical pictureb | Stimulic,d | Diagnosis-test intervald | Lymphocyte count/mm3d | Underlying defecte |
|---|---|---|---|---|---|---|---|
| 46 | F | NIIDf | Idiopathic erythema nodosum | 1 | 2 yr | 1,790 | NP |
| 36 | M | NIID | Hidradenitis | 1 | Continuously | 2,690 | NP |
| 59 | F | NIID | Hidradenitis, pyoderma gangrenosum, ankylosing spondylitis | 2/2 | Continuously | 1,030/510 | NP |
| 50 | F | NIID | Sterile subareolar abscesses | 2 | 19 mo | 3,040 | NP |
| 26 | F | NIID | Episodic fever, abdominal pain, arthralgia | 1 | 17 mo | 1,880 | NP |
| 18 | F | NIID | EBV-driven cutaneous T-cell lymphoma of childhood | 1 | 9 mo | 950 | 232-kb loss in chromosome 16p11.2 |
| 48 | M | Infection | Progressive multifocal leukoencephalopathy | 2 | 5 mo | NAg | NP |
| 51 | M | Infection | Intraocular varicella-zoster virus infection | 1 | 2 mo | 1,990 | NP |
| 49 | F | Infection | Recurrent varicella-zoster virus infection | 2/2 | 1 mo/NA | 1,680/2,660 | NP |
| 61 | M | Infection | Recurrent bacterial skin infection | 1 | 3 wk/10 mo | 1,220/NA | NP |
| 35 | F | Infection | Recurrent impetigo, RVVC | 1/1/1/1 | 4 mo/6 mo/12 mo/14 mo | 1,820/2,300/2,890/1,820 | NP |
| 56 | F | Infection | Disseminated M. avium infection, Legionella dumoffii pneumonia | 1/1 | 1 mo/2 yr | 1,860/1,810 | NP |
| 68 | F | Infection | M. avium and Mycobacterium intracellulare pneumonia | 1 | 4 mo | 1,680 | NP |
| 54 | M | Infection | Mycobacterium chelonae skin infection | 1 | 9 mo | 2,080 | NP |
| 67 | M | Infection | M. abscessus pneumonia, ABPA | 1/1 | 2 mo/2 mo | 810/800 | NP |
| 67 | M | Infection | M. intracellulare pneumonia | 2 | 3 yr 8 mo | 1,700 | NP |
| 34 | V | Infection | Oral and vaginal candidiasis, furunculosis | 1 | 1 wk | 3,140 | NP |
| 20 | F | Infection | Chronic mucocutaneous candidiasis | 2 | Continuously | NA | NP |
| 48 | F | Infection | Persistent oropharyngeal candidiasis, onychomycosis, asplenia, vitiligo | 1 | Continuously | 1,200 | APECED |
| 28 | F | Infection | RVVC, impetigo, hidradenitis, granulomatous intestinal inflammation | 1 | Continuously | 1,500 | HIES |
| 36 | F | Infection | Chronic mucocutaneous candidiasis | 2 | Continuously | 900 | STAT1 mutation |
| 42 | F | Infection | RVVC | 1 | NA | 1,180 | NP |
| 30 | F | Infection | Recurrent oropharyngeal candidiasis | 1 | 2 mo | 1,940 | NP |
| 49 | M | Infection | Disseminated aspergillosis, pulmonary nocardiosis and R. equi infection, Alternaria skin infection | 1 | 3 yr | 990 | CD4 lymphopenia |
| 57 | M | Infection | Skin abscesses, recurrent pneumonia, eczema | 1 | 2 mo | 2,300 | HIES |
| 63 | F | Infection | Aspergillus skull base osteomyelitis | 1 | 3 yr | NA | NP |
| 66 | F | Infection | Recurrent Candida esophagitis, onychomycosis, hypothyroidism | 1 | Continuously | 900 | CMC, STAT1 negative |
F, female; M, male.
EBV, Epstein-Barr virus; RVVC, recurrent vulvovaginal candidiasis; ABPA, allergic bronchopulmonary aspergillosis.
Number of stimuli that resulted in a deficient response.
Data from patients tested more than once are shown separated by a slash in the same column.
NP, not performed; APECED, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; HIES, hyper-IgE syndrome; STAT, signal transducer and activator of transcription; CMC, chronic mucocutaneous candidiasis.
NIID, noninfectious inflammatory disorder.
NA, not available.